Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12

Keyphrases

• Tumor Immunity 100%
• Recombinant Adenovirus 100%
• Intratumoral Injection 100%
• Interleukin-12 (IL-12) 100%
• Splenocytes 40%
• MC38 40%
• Gene Therapy 20%
• Adenovirus 20%
• Immune Response 20%
• CD8+ T Cells 20%
• Cytomegalovirus 20%
• CD4+ 20%
• Antitumor 20%
• Cytotoxic T Lymphocytes 20%
• Adenocarcinoma 20%
• Antigen-presenting Cells 20%
• Biologically Active 20%
• Transcriptional Control 20%
• Complete Regression 20%
• Serum Levels 20%
• Transient Expression 20%
• Immediate-early Gene 20%
• Rechallenge 20%
• Gene Promoter 20%
• Plaque-forming Units 20%
• Recombinant Viral Vectors 20%
• T Helper 1 20%
• Internal Ribosomal Entry Site 20%
• Cytokine Gene Therapy 20%
• Murine Fibrosarcoma 20%
• Clinical Implementation 20%
• Ad Vector 20%
• Immunosuppressive Cytokines 20%
• Infected Tumor 20%

Medicine and Dentistry

• Adenovirus Vector 100%
• Interleukin 12 100%
• Intratumoral Drug Administration 100%
• Cytokine 60%
• Cytotoxic T-Cell 40%
• Gene Therapy 20%
• T-Helper Cell 20%
• Immune Response 20%
• In Vitro 20%
• Gene Linkage 20%
• Cytomegalovirus 20%
• Adenocarcinoma 20%
• Fibrosarcoma 20%
• Immediate Early Gene 20%
• Adenoviridae 20%
• Cancer Gene Therapy 20%
• Transient Expression 20%
• Gene Promoter 20%
• Tumor 20%
• Antigen Presenting Cell 20%
• Internal Ribosome Entry Site 20%
• Lymphocyte 20%

Immunology and Microbiology

• Adenovirus Vector 100%
• Interleukin 12 100%
• Cytokine 60%
• Cytotoxic T-Cell 20%
• T-Helper Cell 20%
• Cytotoxic T Cell 20%
• Splenocyte 20%
• Plaque-Forming Unit 20%
• Antigen-Presenting Cell 20%
• Immune Response 20%
• Adenoviridae 20%
• Cytomegalovirus 20%
• Blood Level 20%
• Immediate Early Gene 20%
• Transient Expression 20%
• Internal Ribosome Entry Site 20%
• Lymphocyte 20%
• Gene Promoter 20%
• In Vitro 20%